Henriette Farkas Selected Research

Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)

1/2022	Overview of SERPING1 Variations Identified in Hungarian Patients With Hereditary Angioedema.
11/2021	Screening for Plasminogen Mutations in Hereditary Angioedema Patients.
4/2021	Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry.
7/2020	A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency.
1/2020	Hereditary angioedema attack: what happens to vasoactive mediators?
2/2019	Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies.
1/2019	Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
8/2018	Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency.
1/2018	Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
1/2018	Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henriette Farkas Research Topics

Disease

88	Hereditary Angioedemas 03/2022 - 12/2003
32	Angioedema 01/2022 - 09/2004
12	Edema (Dropsy) 06/2021 - 12/2003
5	Rare Diseases (Rare Disease) 11/2021 - 01/2011
4	Acquired angioedema 01/2021 - 05/2006
3	Hypersensitivity (Allergy) 04/2021 - 01/2019
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 10/2011
3	Atherosclerosis 01/2019 - 04/2005
3	Neoplasms (Cancer) 03/2011 - 01/2008
2	Infections 04/2022 - 07/2010
2	Inflammation (Inflammations) 04/2022 - 02/2012
2	Anaphylaxis (Anaphylactic Shock) 02/2014 - 01/2011
2	Seasonal Allergic Rhinitis (Hay Fever) 05/2003 - 08/2002
1	Helicobacter Infections 04/2022
1	Insulin Resistance 04/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Erythema 06/2021
1	Vomiting 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Back Pain (Backache) 01/2021
1	Diarrhea 01/2021
1	Thromboembolism 03/2016
1	Polycythemia (Erythrocytosis) 02/2016
1	Cardiac Arrhythmias (Arrythmia) 01/2015
1	Chest Pain (Chest Pains) 01/2015
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Adrenal incidentaloma 01/2014
1	Pruritus (Itching) 04/2013

Drug/Important Bio-Agent (IBA)

21	BradykininIBA 12/2021 - 12/2011
16	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022 - 12/2003
11	Complement System Proteins (Complement)IBA 01/2021 - 06/2003
10	Danazol (Azol)FDA LinkGeneric 01/2019 - 04/2005
9	icatibantIBA 01/2021 - 08/2010
7	AntibodiesIBA 01/2022 - 01/2011
6	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2003
6	AndrogensIBA 01/2022 - 07/2010
6	Pharmaceutical PreparationsIBA 04/2021 - 04/2010
5	Plasma KallikreinIBA 06/2021 - 01/2018
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2008
4	Factor XII (Hageman Factor)IBA 11/2021 - 07/2010
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2016
4	conestat alfaIBA 03/2020 - 11/2008
4	AutoantibodiesIBA 10/2016 - 02/2007
3	berotralstatIBA 06/2021 - 01/2018
3	Kallikreins (Kallikrein)IBA 01/2020 - 01/2018
3	C-Reactive ProteinIBA 01/2019 - 06/2003
3	Tranexamic Acid (AMCA)FDA Link 03/2016 - 08/2010
3	Histamine Antagonists (Antihistamines)IBA 01/2014 - 05/2003
2	alpha-2-HS-GlycoproteinIBA 04/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	Serine Proteases (Serine Protease)IBA 01/2020 - 10/2015
2	Bradykinin B2 ReceptorIBA 01/2020 - 06/2016
2	LipidsIBA 01/2019 - 04/2005
2	Neutralizing AntibodiesIBA 01/2019 - 02/2014
2	Endothelin-1 (Endothelin 1)IBA 02/2016 - 02/2012
2	LectinsIBA 10/2015 - 12/2014
2	EnzymesIBA 10/2015 - 12/2014
2	Hormones (Hormone)IBA 01/2014 - 09/2004
2	Immunoglobulin G (IgG)IBA 01/2012 - 03/2011
2	Immunoglobulin M (IgM)IBA 10/2011 - 01/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2007 - 08/2002
1	PlasminogenIBA 11/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 11/2021
1	Angiopoietin-1IBA 11/2021
1	Glucosamine (Dona)IBA 11/2021
1	Complement C1 (Complement 1)IBA 08/2021
1	Interleukin-8 (Interleukin 8)IBA 06/2021
1	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 01/2021
1	Platelet Activating FactorIBA 01/2020
1	Cholecalciferol (Vitamin D3)FDA Link 06/2019
1	KininsIBA 02/2019
1	lanadelumabIBA 02/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	acivicin (AT 125)IBA 01/2018
1	Investigational DrugsIBA 01/2018
1	Secretory Phospholipases A2IBA 01/2018
1	Kininogens (Kininogen)IBA 12/2017
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2017
1	Biological ProductsIBA 01/2017
1	Atrial Natriuretic Factor (ANF)IBA 04/2016
1	Testosterone (Sustanon)FDA Link 02/2016
1	AdrenomedullinIBA 02/2016
1	Arginine Vasopressin (Argipressin)IBA 02/2016
1	Thyroid HormonesIBA 01/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2015
1	GlucocorticoidsIBA 01/2014
1	Amino Acids FDA Link 10/2013
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2013
1	Proline (L-Proline)FDA Link 10/2013
1	Mannose-Binding Protein-Associated Serine Proteases (Mannose-Binding Protein-Associated Serine Protease)IBA 07/2013
1	FicolinsIBA 07/2013
1	Estrogens (Estrogen)FDA Link 07/2013

Therapy/Procedure

28	Therapeutics 03/2022 - 08/2002
2	Aftercare (After-Treatment) 02/2016 - 12/2012
1	Polypharmacy 01/2020
1	Biological Therapy 01/2020
1	Oral Administration 01/2018
1	Drug Therapy (Chemotherapy) 04/2013